NEVVI Medicare utilization intelligence

← back

BARLOW, BRETTM.D. NPI 1700240264 Clinician

Hematology-Oncology · LAUREL, MS

Specialty Hematology-Oncology — from billed Medicare claims
Trained UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 10 years since medical school (class of 2016, self-reported to CMS)
Location LAUREL, MS · NPPES registered location
Active in data Billed Medicare 2022–2024 (3 consecutive years)
Scale 75 codes billed · 52,645 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20232026
ONCOLOGY SPECIALTIES, P.C.
2023–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2025-12

Year: 2024 · 2023 · 2022 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
80053 Blood test, comprehensive group of blood chemicals
J1750 Injection, iron dextran, 50 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
J1437 Injection, ferric derisomaltose, 10 mg
J1626 Injection, granisetron hydrochloride, 100 mcg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96375 Injection of additional new drug or substance into vein
88185 Flow cytometry technique for dna or cell analysis, each additional marker
82728 Ferritin (blood protein) level
83550 Iron binding capacity
83540 Iron level
J9190 Injection, fluorouracil, 500 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J2469 Injection, palonosetron hcl, 25 mcg
82607 Cyanocobalamin (vitamin b-12) level
96413 Administration of chemotherapy into vein, 1 hour or less
82784 Gammaglobulin (immune system protein) measurement
Q5127 Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg
J3475 Injection, magnesium sulfate, per 500 mg
83883 Nephelometry, test method using light
83735 Magnesium level
84443 Blood test, thyroid stimulating hormone (tsh)
J9045 Injection, carboplatin, 50 mg
J3480 Injection, potassium chloride, per 2 meq
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
83615 Lactate dehydrogenase (enzyme) level
82746 Folic acid level, serum
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
84165 Protein measurement, serum
84100 Phosphate level
J3489 Injection, zoledronic acid, 1 mg
J3490 Unclassified drugs
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96415 Administration of chemotherapy into vein, each additional hour
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
84153 Psa (prostate specific antigen) measurement, total
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96417 Administration of additional new drug or substance into vein, 1 hour or less
82378 Carcinoembryonic antigen (cea) protein level
84439 Thyroxine (thyroid chemical), free
85046 Red blood count automated, with additional calculations
96361 Infusion into a vein for hydration, each additional hour
96411 Administration of additional new drug or substance into vein using push technique
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
J1200 Injection, diphenhydramine hcl, up to 50 mg
81003 Automated urinalysis test
85652 Red blood cell sedimentation rate, to detect inflammation, automated
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96523 Irrigation of implanted venous access drug delivery device
88184 Flow cytometry technique for dna or cell analysis, first marker
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
82668 Erythropoietin (protein) level
J7030 Infusion, normal saline solution , 1000 cc
81206 Translocation analysis (bcr/abl1) major breakpoint
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
81207 Translocation analysis (bcr/abl1) minor breakpoint
96360 Infusion into a vein for hydration, 31-60 minutes
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg
83010 Haptoglobin (serum protein) level
99195 Drawing of blood for a medical problem
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
80061 Blood test, lipids (cholesterol and triglycerides)
81270 Gene analysis (janus kinase 2) variant
85055 Reticulated (young) platelet measurement

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.